<DOC>
	<DOC>NCT01706809</DOC>
	<brief_summary>The primary aim of the present study is to investigate different biomarkers like VEGF, EVGF and others ability to predict time to recidive and progressions free survival.</brief_summary>
	<brief_title>Comparing of Different Biomarkers From Vena Rectalis Superior and Vena Cubiti in Patients Undergoing Low Anterior Resection for Rectum Cancer</brief_title>
	<detailed_description>Patients undergoing LAR for rectum cancer is subjected. Preoperative blood samples from vena rectalis superior and vena cubiti is collected, as well as biopsies from tumor. Preoperative and after 3 month peripheral blood samples is collected. A total of 50 patients will be included in this study. The study is approved by the local scientific ethical committee No. S-20100006</detailed_description>
	<mesh_term>Rectal Neoplasms</mesh_term>
	<criteria>Histological verified cancer The cancer must be located in rectum maximum of 15 cm. Age above 18 Disseminated cancer Perioperative radiochemotherapy Laparoscopy surgery</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2014</verification_date>
</DOC>